Submitted by Anonymous (not verified) on 24 June 2024 - 14:52
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 16, Status: Authorised
Source: